See our tirzepatide research guide for comparison context
Eloralintide (LY3841136): A Selective Amylin Receptor Agonist Eli Lilly also shared Phase 1 data on Eloralintide (LY3841136), a selective amylin receptor agonist that mimics the natural hormone amylin to regulate appetite and blood glucose
Table 4 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin in Adults with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Sitagliptin, Both as Add-on to Metformin In this 26-week, open-label trial, 665 adult patients with type 2 diabetes mellitus on a background of metformin 1,500 mg per day were randomized to liraglutide injection 1.2 mg once daily, liraglutide injection 1.8 mg once daily or sitagliptin 100 mg once daily, all dosed according to approved labeling
So far, GLP-1 injections have been the most effective option for weight loss
It is not approved for use in children, and its safety and effectiveness in younger patients have not been established
While many people choose to take weight loss injections without changing their lifestyle, it is recommended to pair this treatment with a healthy diet
